Saturday Symposium

"Light  treatment, light at night and risk of cancer"

chairs: George C. Brainard and Jo Arendt

George C. Brainard, Ph.D. Director, Light Research Program Professor of Neurology Professor of Pharmacology Jefferson Medical College Thomas Jefferson University Jo Arendt, Ph.D., Emeritus Professor of Endocrinology Centre for Chronobiology University of Surrey, UK	Short introduction of speakers and subject
Eva S. Schernhammer, MD, DrPH Assistant Professor of Medicine Brigham and Women's Hospital and Harvard Medical School, Boston, USA	Risk of cancer in night shift workers. The melatonin hypothesis
David E. Blask, Ph.D., M.D. Senior Research Scientist and Head Laboratory of Chrono-Neuroendocrine Oncology Bassett Research Institute The Mary Imogene Bassett Hospital Cooperstown, NY, and Department of Medicine, Columbia University, NY, USA	Experimental Evidence for Light at Night-Induced Circadian/Melatonin Disruption as a Risk Factor for Human Cancer Growth
Elizabeth Filipski, Ph.D., INSERM U776 "Rythmes Biologiques et Cancers" Université Paris XI, Hôpital Paul Brousse Villejuif, France	Effect of frequent phase-shifts on cancer growth
Johnni Hansen, Ph.D., Head of Research unit, Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark.	Non-day time work and breast cancer risk in different groups - experience from Denmark
	Discussion

return to program